Visual Function Tests in Age-related Macular Degeneration (NCT03275753) | Clinical Trial CompassTerminatedNot Applicable
Visual Function Tests in Age-related Macular Degeneration
Stopped: Study terminated by Sponsor
United States200 participantsStarted 2017-09-21 Plain-language summary
The goal of this study is to assess a battery of visual function tests in subjects with non-exudative age-related macular degeneration
Who can participate
Age range60 Years – 99 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
- ✓. Be 60 years of age or older;
- ✓. Provide written informed consent;
- ✓. Be willing and able to follow all instructions and attend the study visits;
- ✓. Must be able to perform all study procedures;
- ✓. Have BCVA of 20/25 or better in the study eye;
- ✓. Have no history or clinical evidence of AMD, retinal diseases or any other ocular pathologies in either eye;
- ✓. Have BCVA of 20/40 or better in the study eye;
- ✓. Have a clinical diagnosis of non-exudative AMD in the study eye;
Exclusion criteria
- ✕. Have a diagnosis of wet AMD in the study eye;
- ✕. Have any other hereditary or acquired retinal diseases in either eye ;
- ✕. Have glaucoma or other optic nerve diseases in either eye;
- ✕. Have corneal or other anterior segment diseases in either eye;
- ✕. Have significant cataract in the study eye;
- ✕. Have a history of ocular trauma or ocular surgery (other than cataract removal) in the study eye;
What they're measuring
1Critical flicker fusion
Timeframe: At study visit through study completion, an average of 2 years
Trial details
NCT IDNCT03275753
SponsorORA, Inc.
Sponsor typeINDUSTRY
Study typeOBSERVATIONAL
Primary completion2021-12-31